Catecholaminergic polymorphic ventricular tachycardia cost-effectiveness of therapy

Catecholaminergic polymorphic ventricular tachycardia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Exercise Stress Testing
Genetic Testing
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Implantable Cardioverter-Defibrillator
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Catecholaminergic polymorphic ventricular tachycardia cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Catecholaminergic polymorphic ventricular tachycardia cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Catecholaminergic polymorphic ventricular tachycardia cost-effectiveness of therapy
CDC on Catecholaminergic polymorphic ventricular tachycardia cost-effectiveness of therapy
Catecholaminergic polymorphic ventricular tachycardia cost-effectiveness of therapy in the news
Blogs on Catecholaminergic polymorphic ventricular tachycardia cost-effectiveness of therapy
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Catecholaminergic polymorphic ventricular tachycardia cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: